Target intelligence / Profile preview

Synaptosomal-associated protein 25 kDa (SNAP-25)

Target
SNAP-25
Molecular classification
SNARE protein, Membrane fusion protein, Other (t-SNARE; target membrane-associated SNARE)
01

Overview

SNAP-25 is a membrane-associated SNARE protein essential for the calcium-triggered exocytosis of synaptic vesicles at chemical synapses, including cholinergic terminals. It forms a complex with syntaxin-1 and synaptobrevin/VAMP, mediating fusion of neurotransmitter-filled vesicles with the presynaptic membrane to enable acetylcholine release. Absence or cleavage of SNAP-25 abolishes fast synaptic exocytosis. Phosphorylation of SNAP-25 by PKA modulates its activity and synaptic plasticity. SNAP-25 is implicated in several neurological and psychiatric disorders, and is the molecular target of botulinum neurotoxins, which cause neuroparalysis by blocking neurotransmitter release. SNAP-25 is expressed at presynaptic terminals of both cholinergic and other types of neurons (glutamatergic, GABAergic), but is especially well-studied in cholinergic transmission at the neuromuscular junction and central synapses. Its function and post-translational modifications (e.g., phosphorylation, acetylation) shape synaptic efficacy, plasticity, and may underlie disease states or therapeutic mechanisms.

Other names
SNAP25Synaptosomal-associated protein 25t-SNARESN25SuP
02

Mechanism of action

Inhibition (botulinum neurotoxins cleave SNAP-25, blocking neurotransmitter release and causing paralysis); Modulation of SNARE complex stability via phosphorylation (PKA-mediated)

03

Biological functions

Neurotransmitter exocytosisSynaptic transmissionSynaptic plasticityVesicle docking and primingSignal transduction
04

Disease associations

Neurodegenerative diseasePsychiatric disease (schizophrenia, cognitive disorders)Other (botulism: target in neuroparalytic disease)
05

Safety considerations

Neuroparalysis with excessive inhibition (e.g., botulism or therapeutic overdose)Potential off-target CNS effects when modulating SNAP-25 function
06

Interacting drugs

Botulinum neurotoxins (A, C, E), e.g., OnabotulinumtoxinA

2 more in the full profile.

07

Biomarkers

SNAP-25 protein levels (e.g., reduced in schizophrenia; investigational as marker in psychiatric/neurological conditions)Phosphorylated SNAP-25 (e.g., pSNAP-25 T138 for synaptic activity)

Beyond the preview

Go deeper on Synaptosomal-associated protein 25 kDa (SNAP-25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptosomal-associated protein 25 kDa (SNAP-25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call